HIV has become a more manageable condition in recent years, but a full cure remains elusive. Now, scientists have found ...

Curing HIV will be harder than curing cancer. Apart from a few 'miracle' cases, antiretrovirals only suppress HIV, they don't ...

Stanford researchers highlight the potential of EBC-46, a compound derived from Australia’s blushwood tree, in eradicating ...

Under Trump's foreign aid pause, all payments by U.S. Agency for International Development (USAID) stopped on Tuesday - for the first time since the fiscal year began on Oct. 1 - and have not resumed, ...

A series of orders from the Trump administration have the potential to disrupt the delivery of life-saving medications to HIV ...

Hopkins said that lenacapavir was expected to be reviewed by the U.S. Food and Drug Administration in 2025, with the potential to dramatically reduce HIV infection. "This will be a critical next step ...

A new chemical compound has been making a big impression in the fight against cancer in recent years. Now it seems EBC-46, otherwise known as tigilanol tiglate, may also have immense potential for ...

The US State Department has lifted the ban on HIV aid to SA and other low-income after President Donald Trump issued a ...

Human immunodeficiency virus type 1 (HIV-1) targets important cells of our immune system, making infected individuals more ...

A unique reaction in which antibodies bind to other antibodies may help scientists at Scripps Research better understand how ...

today announced the opening of the ACACIA study (Antiretrovirals Combined with Antibodies for HIV-1 Cure in Africa), also ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...